C(6ꢀ)H), 8.69 and 8.70 (2H, 2 × s, C(3)H and C(12)H/C(13)H),
8.84 and 8.91, and 8.87 (4H, comprised of 2 × br s {8.84 and 8.91}
and a tight ABq {8.87}, b-pyrrolic H); m/z (ESI-TOF) 1131.7
(98%), 1132.7 (81%), 1133.7 (100%), 1134.7 (55%), 1135.7 (27%),
1136.7 (11%), 1137.7 (4%); C76H92Cl2N4H+ (MH+) requires 1131.7
(100%), 1132.7 (85%), 1133.7 (99%), 1134.7 (64%), 1135.7 (35%),
1136.7 (15%), 1137.7 (5%); Rf (light petroleum–dichloromethane;
5 : 1) = 0.33. 4: a sample co-chromatographed with and had an
identical 1H NMR to an authentic sample.
C84H98N6O2H+ (MH+) requires 1223.7824 (100%), 1224.7856
(94%), 1225.7889 (44%), 1226.7921 (14%), 1227.7952 (3%); Rf
(light petroleum–dichloromethane; 2 : 1) = 0.24.
2-Acetoxy-5,10,15,20-tetrakis(3ꢀ,5ꢀ-di-tert-
butylphenyl)porphyrin 8
To a solution of 5,10,15,20-tetrakis(3ꢀ,5ꢀ-di-tert-butylphenyl)-
porphyrin 4 (6.70 g, 6.30 mmol) in chloroform (420 cm3) were
added silver acetate (3.00 g, 18.0 mmol) and iodine (3.00 g,
11.8 mmol). The reaction mixture was stirred at room temperature
in the dark under argon for 1.5 h and then filtered through
a short plug of silica gel using dichloromethane as the eluent.
The filtrate was collected and the solvent was removed, and the
residue was purified by column chromatography over silica using
a dichloromethane : light petroleum (gradient from 1 : 6 to 1 : 1) as
eluent to give 9 (0.48 g, 6%), 4 (2.38 g, 36%), 8 (2.62 g, 37%) and 10
(0.31 g, 5%). 9: red solid, mp >280 ◦C; found: C, 76.8%; H, 7.8%;
N, 4.6%; C76H93IN4 requires C, 76.7%; H, 7.9%; N, 4.7%; kmax
(CH2Cl2)/nm (log(e/dm−3 mol−1 cm−1)) 303 (4.19), 369sh (4.40),
424 (5.67), 489 (3.61), 520 (4.35), 556 (3.92), 595 (3.79), 651 (3.85);
1H NMR (400.1 MHz; CDCl3) d: −2.75 (2H, br s, NH), 1.52, 1.525,
12-Acetoxy-5,10,15,20-tetrakis(3ꢀ,5ꢀ-di-tert-
butylphenyl)quinoxalino[2,3-b]porphyrin 3
To a solution of 5,10,15,20-tetrakis(3ꢀ,5ꢀ-di-tert-butylphenyl)-
quinoxalino[2,3-b]porphyrin 1 (100 mg, 0.086 mmol) in chloro-
form (10 cm3) were added silver acetate (50 mg, 0.30 mmol) and
iodine (50 mg, 0.20 mmol). The reaction mixture was stirred at
room temperature in the dark under argon for 1.5 h and then
filtered through a short plug of silica using dichloromethane as the
eluent. The filtrate was collected, the solvent was removed and the
residue was purified by column chromatography over silica using
a dichloromethane : light petroleum mixture (gradient from 1 : 6
to 1 : 2) as eluent to give 12-iodo-5,10,15,20-tetrakis(3ꢀ,5ꢀ-di-tert-
butylphenyl)quinoxalino[2,3-b]porphyrin (6.0 mg, 5%), 1 (44 mg,
44%) and 3 (34 mg, 32%). 12-Iodo-5,10,15,20-tetrakis(3ꢀ,5ꢀ-di-
tert-butylphenyl)quinoxalino[2,3-b]porphyrin: dark purple solid,
mp >280 ◦C; found: C, 76.2%; H, 7.4%; N, 6.4%; C82H95IN6
requires C, 76.3%; H, 7.4%; N, 6.5%); kmax (CH2Cl2)/nm
(log(e/dm−3 mol−1 cm−1)) 296 (4.28), 344sh (4.37), 364sh (4.42),
ꢀ
ꢀ
ꢀ ꢀ
1.53, and 1.54 (72H, 4 × s, t-butyl H), 7.80 (2H, dd, J2 ,4 = J6 ,4
=
2 Hz, C(4ꢀ)H), 7.82 (1H, dd, J2 ,4 = J6 ,4 = 2 Hz, C(4ꢀ)H), 7.83
ꢀ
ꢀ
ꢀ ꢀ
(1H, dd, J2 ,4 = J6 ,4 = 2 Hz, C(4ꢀ)H), 7.94 (2H, d, J4 ,2 = J4 ,6
=
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ ꢀ
2 Hz, C(2ꢀ)H and C(6ꢀ)H), 8.06 (2H, d, J4 ,2 = J4 ,6 = 2 Hz, C(2ꢀ)H
and C(6ꢀ)H), 8.07–8.09 (4H, m, C(2ꢀ)H and C(6ꢀ)H), 8.82 and 8.84
(2H, ABq, JA,B = 4 Hz, b-pyrrolic H), 8.89–8.92 (3H, m, b-pyrrolic
H), 8.96 (1H, 1/2ABq, JA,B = 5 Hz, b-pyrrolic H), 9.21 (1H, s,
C(3)H); m/z (ESI) 1189.6 (100%); C76H93IN4H+ (MH+) requires
1189.6 (100%); Rf (light petroleum–dichloromethane; 5 : 1) = 0.26.
ꢀ
ꢀ
ꢀ ꢀ
1
413sh (5.03), 438 (5.31), 532 (4.32), 600 (4.01), 655 (2.98); H
NMR (400.1 MHz; CDCl3) d: −2.70 (1H, br s, NH), −2.54 (1H,
br s, NH), 1.48, 1.485, 1.53, and 1.54 (72H, 4 × s, t-butyl H), 7.73–
7.77 (2H, m, quinoxalino H), 7.81–7.84 (4H, m, quinoxalino H
1
4: a sample co-chromatographed with and had an identical H
◦
NMR to an authentic sample. 8: red solid, mp >280 C; found:
and C(4ꢀ)H), 7.92 (2H, dd, J2 ,4 = J6 ,4 = 2 Hz, C(4ꢀ)H), 7.95 (4H,
C, 83.6%; H, 8.7%; N, 4.9%; C78H96N4O2 requires C, 83.5%; H,
ꢀ
ꢀ
ꢀ ꢀ
m, C(2ꢀ)H and C(6ꢀ)H), 7.97 (2H, d, J4 ,2 = J4 ,6 = 2 Hz, C(2ꢀ)H
8.6%; N, 5.0%; mmax (KBr)/cm−1 1767 (C O); kmax (CH2Cl2)/nm
=
ꢀ
ꢀ
ꢀ ꢀ
and C(6ꢀ)H), 8.07 (2H, d, J4 ,2 = J4 ,6 = 2 Hz, C(2ꢀ)H and C(6ꢀ)H),
(log(e/dm−3 mol−1 cm−1)) 304 (3.86), 327sh (3.81), 371sh (4.05), 421
(5.34), 486 (3.26), 517 (3.95), 553 (3.61), 591 (3.42), 647 (3.38); 1H
NMR (400.1 MHz; CDCl3) d: −2.77 (2H, br s, NH), 1.53 (18H, s,
t-butyl H), 1.54 (18H, s, t-butyl H), 1.55 (36H, s, t-butyl H), 1.82
ꢀ
ꢀ
ꢀ ꢀ
8.93 (1H, dd, Jb,b = 5 Hz, JNH,b = 1.5 Hz, b-pyrrolic H), 8.95 (1H,
dd, Jb,b = 5 Hz, JNH,b = 1.5 Hz, b-pyrrolic H), 9.01 (1H, dd, Jb,b
=
5 Hz, JNH,b = 1.5 Hz, b-pyrrolic H), 9.05 (1H, dd, Jb,b = 5 Hz,
JNH,b = 1.5 Hz, b-pyrrolic H), 9.14 (1H, s, C(13)H); m/z (ESI-
TOF) 1291.5 (MH+, 100%); C82H95N6IH+ requires 1291.7 (MH+);
Rf (light petroleum–dichloromethane; 5 : 1) = 0.25. 1: a sample
(3H, s, CH3COO), 7.80 (4H, br m, C(4ꢀ)H), 8.00 (2H, d, J4 ,2
=
ꢀ
ꢀ
J4 ,6 = 1.5 Hz, C(2ꢀ)H and C(6ꢀ)H), 8.09 (2H, d, J4 ,2 = J4 ,6
=
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ ꢀ
1.5 Hz, C(2ꢀ)H and C(6ꢀ)H), 8.10 (4H, d, J4 ,2 = J4 ,6 = 1.5 Hz,
ꢀ
ꢀ
ꢀ ꢀ
1
co-chromatographed with and had an identical H NMR to an
C(2ꢀ)H and C(6ꢀ)H), 8.61 (1H, s, C(3)H), 8.68 and 8.90 (2H, ABq,
authentic sample. 3: orange–brown solid, mp >280 ◦C; found: C,
JA,B = 5 Hz, b-pyrrolic H), 8.84 and 8.86 (2H, tight ABq, JA,B =
82.4%; H, 8.1%; N, 6.85%; C84H98N6O2 requires C, 82.45%; H,
5 Hz, b-pyrrolic H), 8.92 and 8.95 (2H, ABq, JA,B = 5 Hz, b-
pyrrolic H); m/z (ESI-TOF) 1121.7546 (100%), 1122.7572 (86%),
1123.7642 (32%), 1124.7635 (8%), 1125.7638 (2%); C78H96N4O2H+
(MH+) requires 1121.7606 (100%), 1122.7639 (87%), 1123.7672
(38%), 1124.7704 (11%), and 1125.7736 (2%); Rf (light petroleum–
dichloromethane; 2 : 1) = 0.27. 10: red solid, mp >280 ◦C; found:
C, 81.5%; H, 8.3%; N, 4.7%; C80H98N4O4 requires C, 81.45%; H,
8.1%; N, 6.9%; mmax (KBr)/cm−1 1766 (C O); kmax (CH2Cl2)/nm
=
(log(e/dm−3 mol−1 cm−1)) 294 (4.36), 339sh (4.40), 356 (4.45), 433
1
(5.35), 529 (4.28), 562 (3.74), 598 (4.00), 650 (2.97); H NMR
(400.1 MHz; CDCl3) d: −2.67 (1H, br s, NH), −2.61 (1H, br s,
NH), 1.48, 1.49, 1.52, and 1.54 (72H, 4 × s, t-butyl H), 1.79 (3H, s,
CH3COO), 7.72–7.76 (2H, m, quinoxalino H), 7.80–7.85 (4H, m,
C(4ꢀ)H and quinoxalino H), 7.92–7.94 (2H, m, C(4ꢀ)H), 7.96 (2H,
8.4%; N, 4.75%; mmax (KBr)/cm−1 1768 (C O); kmax (CH2Cl2)/nm
=
d, J4 ,2 = J4 ,6 = 2 Hz, C(2ꢀ)H and C(6ꢀ)H), 7.98 (2H, d, J4 ,2
=
(log(e/dm−3 mol−1 cm−1)) 307 (4.27), 379sh (4.44), 402sh (5.04), 421
(5.69), 489sh (3.67), 518 (4.38), 553 (3.96), 590 (3.87), 645 (3.77);
1H NMR (500.3 MHz; CD2Cl2) d: −2.93 (2H, br s, NH), 1.50,
1.51, 1.52 and 1.53 (72H, 4 × s, t-butyl H), 1.78 (6H, s, CH3COO),
7.77–7.78 (4H, m, C(4ꢀ)H), 7.95–7.97 (4H, m, C(2ꢀ)H and C(6ꢀ)H),
8.06–8.08 (4H, m, C(2ꢀ)H and C(6ꢀ)H), 8.53 and 8.55 (2H, 2 × s,
C(3)H and C(12)H or C(13)H), 8.63 (1H, br s, b-pyrrolic H), 8.67
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ ꢀ
J4 ,6 = 1.5 Hz, C(2ꢀ)H and C(6ꢀ)H), 8.00 (2H, d, J4 ,2 = J4 ,6
=
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ ꢀ
2 Hz, C(2ꢀ)H and C(6ꢀ)H), 8.11 (2H, d, J4 ,2 = J4 ,6 = 2 Hz, C(2ꢀ)H
ꢀ
ꢀ
ꢀ ꢀ
and C(6ꢀ)H), 8.52 (1H, s, C(13)H), 8.72 and 9.01 (2H, ABq, JA,B
=
4.5 Hz, b-pyrrolic H), 8.95 and 9.06 (2H, ABq, JA,B = 4.5 Hz,
b-pyrrolic H); m/z (ESI-TOF) 1223.8216 (100%), 1224.8205
(93%), 1225.8266 (39%), 1226.8217 (11%), 1227.8259 (3%);
884 | Org. Biomol. Chem., 2008, 6, 879–886
This journal is
The Royal Society of Chemistry 2008
©